Data from Cempra’s CEM-101 Phase 2 trial on N. gonorrhoeae infections to be presented at ECCMID – News-Medical.Net

gonorrhoeae that displayed a variety of antibiotic resistance profiles.  Solithromycin is a fourth-generation macrolide that has demonstrated potent activity against a broad spectrum of pathogens including bacteria resistant to other macrolides. 

Leave a Reply

Your email address will not be published.